Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel naphthyridine derivatives disclosed by Jiangsu Simcere Pharmaceutical R&D

Oct. 31, 2013

New serotonin 5-HT reuptake inhibitors patented for pain and depression

Oct. 31, 2013

Activity of neuromuscular blocking agent CW-1759-50 described in monkeys

Oct. 31, 2013

Cara Therapeutics reports results from phase II trial of CR-845

Oct. 30, 2013

University of South Florida discloses new myricanol derivatives

Oct. 30, 2013

ADAM10: potential target and genetic marker for late-onset AD

Oct. 30, 2013

FDA extends approval of Lundbeck's Sabril

Oct. 29, 2013

Amorfix Life Sciences detects misfolded SOD1 in sporadic ALS

Oct. 29, 2013

Columbia University prepares new ferroptosis modulators

Oct. 29, 2013

Cells of a patient with Unverricht-Lundborg disease corrected for splice defect

Oct. 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...